2021
DOI: 10.1098/rsob.210276
|View full text |Cite
|
Sign up to set email alerts
|

MYC regulates metabolism through vesicular transfer of glycolytic kinases

Abstract: Amplification of the proto-oncogene MYCN is a key molecular aberration in high-risk neuroblastoma and predictive of poor outcome in this childhood malignancy. We investigated the role of MYCN in regulating the protein cargo of extracellular vesicles (EVs) secreted by tumour cells that can be internalized by recipient cells with functional consequences. Using a switchable MYCN system coupled to mass spectrometry analysis, we found that MYCN regulates distinct sets of proteins in the EVs … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 47 publications
0
5
0
Order By: Relevance
“…Despite strong mRNA and protein validation of the PKM isoform switching, metabolic tracing did not show any consistent effects on glucose metabolism; additionally oxidative phosphorylation was also unaltered (data not shown). However, PKM2 also phosphorylates non-metabolic substrates, for example stabilizing Bcl-2 (61) and influencing transcription via phosphorylation of histone 3, already demonstrated in neuroblastoma (62), and perturbation of these pathways may contribute to GSK3203591-mediated growth inhibition. Numerous other DEGs and DSGs identified by our transcriptomic analyses encode metabolic pathway proteins.…”
Section: Discussionmentioning
confidence: 99%
“…Despite strong mRNA and protein validation of the PKM isoform switching, metabolic tracing did not show any consistent effects on glucose metabolism; additionally oxidative phosphorylation was also unaltered (data not shown). However, PKM2 also phosphorylates non-metabolic substrates, for example stabilizing Bcl-2 (61) and influencing transcription via phosphorylation of histone 3, already demonstrated in neuroblastoma (62), and perturbation of these pathways may contribute to GSK3203591-mediated growth inhibition. Numerous other DEGs and DSGs identified by our transcriptomic analyses encode metabolic pathway proteins.…”
Section: Discussionmentioning
confidence: 99%
“… 71 The LC-MS analysis were performed as previously described. 10 , 38 , 72 The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 73 partner repository with the dataset identifier PXD030391 and 10.6019/PXD030391.…”
Section: Methodsmentioning
confidence: 99%
“…Cancer cells have known to mainly rely on aerobic glycolysis for sustained growth and metastasis, and specifically to adapt to new environment at secondary locations. In MYCN-amplified NBs, MYCN was found to transfer such aggressive, oncogenic phenotype to other non-MYCN amplified NB cells and surrounding stromal cells by regulating the host cell EV-protein cargo thereby promoting tumor progression ( 75 ).…”
Section: Role Of Evs In Nb Progressionmentioning
confidence: 99%